Rethinking Lupus Nephritis Classification on a Molecular Level
Authors:
- Salem AlmaaniSASalem Almaani
- Stephenie D. ProkopecSPStephenie D. Prokopec
- Jianying ZhangJZJianying Zhang
- Lianbo YuLYLianbo Yu
- Carmen Avila-CasadoCACarmen Avila-Casado
- Joan WitherJWJoan Wither
- James W. ScholeyJSJames W. Scholey
- Valeria AlbertonVAValeria Alberton
- Ana MalvarAMAna Malvar
- Samir V. ParikhSPSamir V. Parikh
- Paul C. BoutrosPBPaul C. Boutros
- Brad H. RovinBRBrad H. Rovin
Open Access
- 23 September 2019
- journal article
- research article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 8 (10) , 1524
Abstract
The International Society of Nephrology/Renal Pathology Society (ISN/RPS) lupus nephritis (LN) classification is under reconsideration, given challenges with inter-rater reliability and resultant inconsistent relationship with treatment response. Integration of molecular classifiers into histologic evaluation can improve diagnostic precision and identify therapeutic targets. This study described the relationship between histological and molecular phenotypes and clinical responses in LN. Renal compartmental mRNA abundance was measured in 54 biopsy specimens from LN patients and correlated to ISN/RPS classification and individual histologic lesions. A subset of transcripts was also evaluated in sequential biopsies of a separate longitudinal cohort of 36 patients with paired samples obtained at the time of flare and at follow up. Unsupervised clustering based on mRNA abundance did not demonstrate a relationship with the (ISN/RPS) classification, nor did univariate statistical analysis. Exploratory analyses suggested a correlation with individual histologic lesions. Glomerular FN1 (fibronectin), SPP1 (secreted phosphoprotein 1), and LGALS3 (galectin 3) abundance correlated with disease activity and changed following treatment. Exploratory analyses suggested relationships between specific transcripts and individual histologic lesions, with the important representation of interferon-regulated genes. Our findings suggested that the current LN classification could be refined by the inclusion of molecular descriptors. Combining molecular and pathologic kidney biopsy phenotypes may hold promise to better classify disease and identify actionable treatment targets and merits further exploration in larger cohorts.Keywords
Funding Information
- Alliance for Lupus Research (.)
This publication has 46 references indexed in Scilit:
- Plasma levels of osteopontin identify patients at risk for organ damage in systemic lupus erythematosusArthritis Research & Therapy, 2013
- INTERFEROME v2.0: an updated database of annotated interferon-regulated genesNucleic Acids Research, 2012
- Proliferative lesions and metalloproteinase activity in murine lupus nephritis mediated by type I interferons and macrophagesProceedings of the National Academy of Sciences, 2010
- Key role of ERK pathway signaling in lupusAutoimmunity, 2009
- Renal expression of galectin-3 in systemic lupus erythematosus patients with nephritisLupus, 2009
- Value of a Complete or Partial Remission in Severe Lupus NephritisClinical Journal of the American Society of Nephrology, 2008
- Molecular approaches to chronic kidney diseaseCurrent Opinion in Nephrology and Hypertension, 2006
- Exploration, normalization, and summaries of high density oligonucleotide array probe level dataBiostatistics, 2003
- Interferon and Granulopoiesis Signatures in Systemic Lupus Erythematosus BloodJournal of Experimental Medicine, 2003
- TGF-β1 induces proliferation in human renal fibroblasts via induction of basic fibroblast growth factor (FGF-2)Kidney International, 2001